Literature DB >> 18608757

Synthesis and preliminary evaluation of new ursolic and oleanolic acids derivatives as antileishmanial agents.

Simone C B Gnoatto1, Luciana Dalla Vechia, Claiton L Lencina, Alexandra Dassonville-Klimpt, Sophie Da Nascimento, Djavad Mossalayi, Jean Guillon, Grace Gosmann, Pascal Sonnet.   

Abstract

A series of new ursolic and oleanolic acids derivatives was synthesized via ursolic or oleanolic acids, previously extracted from South American Ilex species. These new compounds were tested for in vitro antiparasitic activity on Leishmania amazonensis and Leishmania infantum strains. Some of these compounds showed activity against the promastigote forms of L. amazonensis or L. infantum, with IC(50) ranging from 5 to 12 microM. As expected, most of the compounds showed a significant level of cytotoxicity against monocytes (IC(50) = 2-50 microM). From a structure-activity relationships point of view, these pharmacological results enlightened mainly the importance of an acetylation at position 3 of the oleanolic acid skeleton in the activity against the L. amazonensis strain, and of a bis-(3-aminopropyl)piperazine moiety on the carboxylic function of ursolic acid against the L. infantum strain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18608757     DOI: 10.1080/14756360802204870

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  8 in total

1.  Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity.

Authors:  Komal Kalani; Dharmendra Kumar Yadav; Feroz Khan; Santosh K Srivastava; Nitasha Suri
Journal:  J Mol Model       Date:  2012-01-21       Impact factor: 1.810

2.  Anti-leishmanial effects of purified compounds from aerial parts of Baccharis uncinella C. DC. (Asteraceae).

Authors:  Luiz Felipe D Passero; Alexis Bonfim-Melo; Carlos Eduardo P Corbett; Márcia D Laurenti; Marcos H Toyama; Daniela O de Toyama; Paulete Romoff; Oriana A Fávero; Simone S dos Grecco; Cynthia A Zalewsky; João Henrique G Lago
Journal:  Parasitol Res       Date:  2010-10-01       Impact factor: 2.289

3.  Anti-Trichomonas vaginalis activity from triterpenoid derivatives.

Authors:  Adrine Maria Innocente; Patrícia de Brum Vieira; Amanda Piccoli Frasson; Bruna Bento Casanova; Grace Gosmann; Simone Cristina Baggio Gnoatto; Tiana Tasca
Journal:  Parasitol Res       Date:  2014-06-01       Impact factor: 2.289

4.  A lupane-triterpene isolated from Combretum leprosum Mart. fruit extracts that interferes with the intracellular development of Leishmania (L.) amazonensis in vitro.

Authors:  Carolina Bioni Garcia Teles; Leandro Soares Moreira-Dill; Alexandre de Almeida Silva; Valdir Alves Facundo; Walter F de Azevedo; Luiz Hildebrando Pereira da Silva; Maria Cristina M Motta; Rodrigo Guerino Stábeli; Izaltina Silva-Jardim
Journal:  BMC Complement Altern Med       Date:  2015-06-06       Impact factor: 3.659

Review 5.  Antimicrobial activity of oleanolic and ursolic acids: an update.

Authors:  Jéssica A Jesus; João Henrique G Lago; Márcia D Laurenti; Eduardo S Yamamoto; Luiz Felipe D Passero
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-22       Impact factor: 2.629

6.  Therapeutic effect of ursolic acid in experimental visceral leishmaniasis.

Authors:  Jéssica A Jesus; Thais N Fragoso; Eduardo S Yamamoto; Márcia D Laurenti; Marcelo S Silva; Aurea F Ferreira; João Henrique G Lago; Gabriela Santos-Gomes; Luiz Felipe D Passero
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-12-08       Impact factor: 4.077

7.  Synthesis of acyl oleanolic acid-uracil conjugates and their anti-tumor activity.

Authors:  Wei-Bin Mo; Chun-Hua Su; Jia-Yan Huang; Jun Liu; Zhen-Feng Chen; Ke-Guang Cheng
Journal:  Chem Cent J       Date:  2016-11-21       Impact factor: 4.215

8.  The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis.

Authors:  Eduardo S Yamamoto; Bruno L S Campos; Jéssica A Jesus; Márcia D Laurenti; Susan P Ribeiro; Esper G Kallás; Mariana Rafael-Fernandes; Gabriela Santos-Gomes; Marcelo S Silva; Deborah P Sessa; João H G Lago; Débora Levy; Luiz F D Passero
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.